Clin2
NCT07634770Possibly a fitRecruiting

Oral insulin study compared to injected insulin

Diabetes Mellitus, Type 1

Part of Hormones & metabolism, Immune system & allergy clinical trials.

This early-stage study tests whether a new oral (swallowed) form of insulin called SCD0503 works as well as regular injected insulin in men with type 1 diabetes. Researchers will also check how food affects how your body absorbs the oral insulin.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
16 people
Ages
18 years to 64 years
Study type
Interventional

Who can take part

  • You are a man with type 1 diabetes diagnosed at least 12 months ago
  • You are between 18 and 64 years old with a healthy weight (BMI 18.5–29.9)
  • Your blood sugar control is reasonably good (HbA1c of 8.5% or lower)
  • You take less than 1.2 insulin units per kilogram of body weight per day
  • Your insulin doses have stayed the same for at least 2 months before the study
  • Your kidneys, heart, and eyes are generally healthy with no severe diabetes complications

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06945406Recruiting· Phase 1
Study of an investigational drug for diabetes

This trial tests a new medicine, LY4057996, in people with type 1 or type 2 diabetes and in healthy volunteers. It aims to see if the drug is safe and how it works in the body.

Neuss
NCT07535307Recruiting· Phase 1
Testing NNC0487-0111 to regulate insulin in type 2 diabetes

This early-stage study tests a new experimental drug (NNC0487-0111) designed to help regulate insulin levels in adults with type 2 diabetes. Researchers want to see if it works safely and effectively when combined with your current diabetes medications.

Neuss
NCT07186660Recruiting· Phase 2
Studying a new insulin sensitizer for type 1 diabetes

This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.

Charlottesville, Virginia
NCT06731075Not yet recruiting· Phase 3
Oral insulin for type 2 diabetes management

This trial tests an oral insulin capsule (ORMD-0801) for people with type 2 diabetes. It aims to see if the capsule can help control blood sugar safely, possibly offering an alternative to injections.

Dallas, Texas
NCT07308184Not yet recruiting· Phase 3
Study of a new diabetes injection for type 2 diabetes

This study is testing a new injectable medication (IN-B00009) to see if it helps lower blood sugar in people with type 2 diabetes who are not currently on diabetes medicine. It might be an option if diet and exercise alone are not enough to control your diabetes.

NCT06117449Not yet recruiting
Insulin therapy study for type 2 diabetes patients

This study compares how well insulin works versus oral diabetes pills in people with type 2 diabetes. It looks at how effective the treatment is and how satisfied patients feel.

Hear when a new Diabetes Mellitus, Type 1 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.